Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06328647 · ClinicalTrials.gov registry record · NA

Quantra Point-of-Care Hemostasis Monitoring

A NA study of Bleeding and Hemostatic Disorder, sponsored by The Cleveland Clinic.

Recruiting
Registry status
NA
Development phase
666
Enrollment target
1
Study location

NCT06328647 is a NA study of Bleeding and Hemostatic Disorder that is actively recruiting participants, run by The Cleveland Clinic. The registered enrollment target is 666 participants, below the 1,456-participant average among 23 other Bleeding trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06328647, a NA study of Bleeding and Hemostatic Disorder, is actively recruiting participants, sponsored by The Cleveland Clinic.

RECRUITING
Registry status
NA
Development phase
666 participants
Enrollment target
1
Study location

Study Summary

The investigators will test the hypothesis that utilization of a blood and blood component transfusion algorithm guided by the POC Quantra QPlus System in patients undergoing complex cardiac surgery will reduce RBC, plasma, cryoprecipitate, and platelet transfusion during surgery and the first 12 postoperative hours, compared to standard of care (central laboratory transfusion monitoring at the primary anesthesia provider's discretion).

Conditions Studied

Bleeding Hemostatic Disorder

Interventions

  • DEVICE POC Quantra QPlus System
  • OTHER Routine care

Study Locations (1)

Ohio

  • Cleveland Clinic Foundation - Cleveland

Trial Details

FieldValue
Enrollment Target 666 participants
Start Date 2024-10-03
Est. Completion 2026-12-31
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06328647

The ClinicalTrials.gov registry entry for NCT06328647 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 666 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,456-participant average among 23 other Bleeding trials with a reported enrollment target (54% lower). The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bleeding appearing as the primary indexed condition, and to 2 interventions - of which POC Quantra QPlus System is the first listed.

NCT06328647 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT06328647 about?

NCT06328647 is a clinical study titled "Quantra Point-of-Care Hemostasis Monitoring". The investigators will test the hypothesis that utilization of a blood and blood component transfusion algorithm guided by the POC Quantra QPlus System in patients undergoing complex cardiac surgery will reduce RBC, plasma, cryoprecipitate, and platelet transfusion during surgery and the first 12 po...

What is the current status of trial NCT06328647?

This trial is currently recruiting. It is a NA study. The enrollment target is 666 participants. The study started on 2024-10-03. Estimated completion is 2026-12-31.

What conditions does trial NCT06328647 study?

This clinical trial studies the following conditions: Bleeding, Hemostatic Disorder.

What interventions are being tested in trial NCT06328647?

The interventions under investigation include: POC Quantra QPlus System (DEVICE), Routine care (OTHER).

Who is sponsoring clinical trial NCT06328647?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06328647 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Bleeding

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Bleeding

All registered trials for this condition

Hemostatic Disorder

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.